Almac to Feature New Enhancements to its Integrated Supply Chain Management and Patient Compliance Services at the Annual DIA Meeting in Chicago

Almac announced that it will showcase new enhancements to its suite of Integrated Supply Chain Management and Patient Compliance Services at the 47th Annual DIA Meeting in Chicago, IL. The new services (Shipping Temperature Electronic Monitoring System (STEMS), SMS/Text patient reminders, and consultation on packaging and labeling designs to improve patient compliance) are designed to support Almac’s objective of Making Clinical Trials Work BetterTM for patients, sites, and sponsors.

STEMS is a web-enabled, fully-validated data management system that assures pharmaceutical products are monitored within acceptable temperature ranges during shipping. STEMS provides immediate visibility on upload of shipment temperature reports and allows users to make instant decisions on temperature data essential to management of drug supplies. Providing online data access to sponsors is important to reduce quarantine times in trials where the period from shipment-receipt to dispensation to the patient is limited. This is a key enhancement to Almac’s integrated drug supply management solution that includes Manufacturing & Blinding, Patient Screening and Enrollment, Biostatistical Services, Randomization & Drug Assignment, Packaging and Labeling, Global Distribution & Depot Network, QP Release & Analytical Support, Cold Chain Storage and Shipping Temperature Electronic Monitoring System (STEMS), Drug Inventory Management, Patient Compliance programs, Study Closeout/Drug Reconciliation, IXRS® Technology (IVR/IWR),  and Data Integration & Reporting.

Almac will also feature new enhancements to its Patient Compliance service offering at the DIA Conference. As part of its effort to improve patient compliance from initial recruitment to study closeout, Almac will showcase new components of its service offerings: Consulting on Packaging and Label Design for trial supplies and patient reminder services. The latter involves sending patients electronic reminders for a variety of tasks during a clinical trial, such as attending site visits, taking medication, fasting before laboratory visits, and completing Electronic Patient Reported Outcomes (ePRO) diaries, among others.

To reinforce its focus on patient management and integrated services, Almac’s industry experts Graham Nicholls, Director of Biostatistics, Hannah O’Gorman, Product Manager of ePRO, and Jennifer Ross, Senior Biostatistician will speak at the DIA conference on topics relating to ePRO, as well as patient retention and compliance in clinical trials.